Stuart Baker
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Stuart Baker has a total of 59 co-authors. Here are the top co-authors by number of shared publications:
- Alexis Tabah
Queensland University of Technology
2 shared publications - Mahesh Ramanan
Faculty of Health, Queensland University of Technology, Brisbane, Queensland, Australia
2 shared publications A. Palermo
St John of God, Australia
1 shared publicationAdrian Barnett
Australian Centre for Health Services Innovation and Centre for Healthcare Transformation, School of Public Health & Social Work, Queensland University of Technology, QLD, Australia
1 shared publication- Adrian Regli
Intensive Care Unit, SJOG Murdoch Hospital, Murdoch, WA, Australia; Intensive Care Unit, Fiona Stanley Hospital, Murdoch, WA, Australia; Division of Emergency Medicine, Anaesthesia and Pain Medicine, Medical School, The University of Western Australia, Nedlands, WA, Australia; Medical School, The University of Notre Dame, Fremantle, WA, Australia
1 shared publication Alan H. Rashid
1 shared publication
Latest Publications
- 11 August 2025
- Published by Elsevier in Australian Critical Care
- Vol. 38 (6) , 101302
Findings of a pilot randomised controlled trial of an early psychiatric assessment, referral, and intervention study for intensive care patients
- 11 August 2025
- Published by Elsevier in Australian Critical Care
- Vol. 38 (6) , 101302
Findings of a pilot randomised controlled trial of an early psychiatric assessment, referral, and intervention study for intensive care patients
- 4 December 2024
- Published by Elsevier in Australian Critical Care
- Vol. 38 (2) , 101144
In-person, virtual visiting and telephone calls in Australia and New Zealand intensive care units: A point prevalence multicentre study mapping daytime and nighttime interactions
- 4 December 2024
- Published by Elsevier in Australian Critical Care
- Vol. 38 (2) , 101144
In-person, virtual visiting and telephone calls in Australia and New Zealand intensive care units: A point prevalence multicentre study mapping daytime and nighttime interactions
- 1 March 2018
- Published by Elsevier in Australian Critical Care
- Vol. 31 (2) , 114
Intravenous administration set (infusion tubing) replacement after 4 or 7 days is equally effective to prevent bloodstream infections (RSVP trial)
- 1 March 2018
- Published by Elsevier in Australian Critical Care
- Vol. 31 (2) , 114
Intravenous administration set (infusion tubing) replacement after 4 or 7 days is equally effective to prevent bloodstream infections (RSVP trial)
- Open Access
- 1 May 2017
- Published by SAGE Publications in Anaesthesia and Intensive Care
- Vol. 45 (3) , 359-364
A Snapshot of the Oxygenation of Mechanically Ventilated Patients in One Australian Intensive Care Unit
Hyperoxaemia in patients undergoing mechanical ventilation (MV) has been found to be an independent predictor of worse outcome and in-hospital mortality in some conditions. Data suggests that a fraction of inspired oxygen (FiO 2 ) of 0.4 or lower may produce hyperoxaemia although it is commonly accepted without adjustment in ventilator settings. The primary aim of this study was to observe current practice at one Australian tertiary intensive care unit (ICU) with regard to prescription and titration of oxygen (O 2 ) in patients undergoing MV, in particular whether they received higher FiO 2 than required according to arterial blood gas (ABG) results, and whether there was FiO 2 titration as a response to initial ABG results during the 12 hours following. A retrospective observational study of 151 ICU patients undergoing MV between November 2013 and February 2014 was conducted, with ABGs as the primary outcome measure. There were 250 ABG measures, with mean FiO 2 0.38 (range 0.3–1.0) and mean PaO 2 114 mmHg (standard deviation 36). Over all observations, 197 (79%) were of FiO 2 ≤0.4, however no patients were ventilated on room air (FiO 2 0.21) and 114 (46%) were in the hyperoxaemic range. Oxygen titration (up or down) occurred in 31% of patients. Morning ABGs were taken at a time suggested by ICU guidelines, and on review of these measures, the mean FiO 2 was lower than that purported to create toxicity. Subsequently, almost one-third of the cohort had their FiO 2 titrated, however there was a floor effect whereby 39%–43% of the cohort received an FiO 2 of 0.3.
- 1 May 2017
- Published by SAGE Publications in Anaesthesia and Intensive Care
- Vol. 45 (3) , 359-364
Open AccessA Snapshot of the Oxygenation of Mechanically Ventilated Patients in One Australian Intensive Care Unit
Hyperoxaemia in patients undergoing mechanical ventilation (MV) has been found to be an independent predictor of worse outcome and in-hospital mortality in some conditions. Data suggests that a fraction of inspired oxygen (FiO 2 ) of 0.4 or lower may produce hyperoxaemia although it is commonly accepted without adjustment in ventilator settings. The primary aim of this study was to observe current practice at one Australian tertiary intensive care unit (ICU) with regard to prescription and titration of oxygen (O 2 ) in patients undergoing MV, in particular whether they received higher FiO 2 than required according to arterial blood gas (ABG) results, and whether there was FiO 2 titration as a response to initial ABG results during the 12 hours following. A retrospective observational study of 151 ICU patients undergoing MV between November 2013 and February 2014 was conducted, with ABGs as the primary outcome measure. There were 250 ABG measures, with mean FiO 2 0.38 (range 0.3–1.0) and mean PaO 2 114 mmHg (standard deviation 36). Over all observations, 197 (79%) were of FiO 2 ≤0.4, however no patients were ventilated on room air (FiO 2 0.21) and 114 (46%) were in the hyperoxaemic range. Oxygen titration (up or down) occurred in 31% of patients. Morning ABGs were taken at a time suggested by ICU guidelines, and on review of these measures, the mean FiO 2 was lower than that purported to create toxicity. Subsequently, almost one-third of the cohort had their FiO 2 titrated, however there was a floor effect whereby 39%–43% of the cohort received an FiO 2 of 0.3.
- Open Access
- 1 March 2013
- Published by Elsevier in Critical Care and Resuscitation
- Vol. 15 (1) , 8-14
A case series of critically ill patients with anti-N-methyl-Daspartate receptor encephalitis
- 1 March 2013
- Published by Elsevier in Critical Care and Resuscitation
- Vol. 15 (1) , 8-14
Open AccessA case series of critically ill patients with anti-N-methyl-Daspartate receptor encephalitis
- Open Access
- 1 December 2011
- Published by Elsevier in Critical Care and Resuscitation
- Vol. 13 (4) , 271-274
Brain death determination in Australia and New Zealand: a survey of intensive care units
- 1 December 2011
- Published by Elsevier in Critical Care and Resuscitation
- Vol. 13 (4) , 271-274
Open AccessBrain death determination in Australia and New Zealand: a survey of intensive care units
- Open Access
- 1 March 2007
- Published by Elsevier in Critical Care and Resuscitation
- Vol. 9 (1) , 40-50
Attitudes of relatives of patients in intensive care and emergency departments to surrogate consent to research on incapacitated participants
- 1 March 2007
- Published by Elsevier in Critical Care and Resuscitation
- Vol. 9 (1) , 40-50
Open AccessAttitudes of relatives of patients in intensive care and emergency departments to surrogate consent to research on incapacitated participants
- Open Access
- 1 December 2002
- Published by Oxford University Press (OUP) in Biology of Reproduction
- Vol. 67 (6) , 1726-1733
Mouse Ovarian Follicles Secrete Factors Affecting the Growth and Development of Like-Sized Ovarian Follicles In Vitro1
A series of experiments have been carried out to determine whether follicles secrete factors able to affect the growth and development of other, like-sized follicles. Late preantral mouse ovarian follicles were either cocultured or cultured in media conditioned by previously cultured follicles. In particular, the experiments examined whether follicles do secrete such factors, whether the level of FSH in the culture media can affect that process, and what the nature of such secretory factor(s) might be. First, pairs of follicles were cocultured across a polycarbonate membrane containing pores. This showed that communication between the follicles resulted in the stimulation of growth and that the stimulation was due, at least in part, to the production of secretory factor(s). In subsequent experiments, follicles were cultured in media that had been preconditioned by previously cultured follicles. The concentration of FSH in the cultures determined the effect of the conditioned media: conditioned media was stimulatory to follicle growth when levels of FSH remained high throughout the culture, but inhibitory when FSH levels were dropped midway through the cultures. Heat inactivation removed this inhibitory effect, showing that the factor was likely to be a protein; addition of follistatin to the conditioned media did not alter its effect, indicating that the factor was unlikely to be activin. We have shown through a series of culture experiments that mouse follicles secrete factor(s) that can affect the development of other like-sized follicles when cultured from the late preantral to Graafian stages. Furthermore, we have shown that the effect (or production) of such factors is dependent on the FSH environment of the follicles.
- 1 December 2002
- Published by Oxford University Press (OUP) in Biology of Reproduction
- Vol. 67 (6) , 1726-1733
Open AccessMouse Ovarian Follicles Secrete Factors Affecting the Growth and Development of Like-Sized Ovarian Follicles In Vitro1
A series of experiments have been carried out to determine whether follicles secrete factors able to affect the growth and development of other, like-sized follicles. Late preantral mouse ovarian follicles were either cocultured or cultured in media conditioned by previously cultured follicles. In particular, the experiments examined whether follicles do secrete such factors, whether the level of FSH in the culture media can affect that process, and what the nature of such secretory factor(s) might be. First, pairs of follicles were cocultured across a polycarbonate membrane containing pores. This showed that communication between the follicles resulted in the stimulation of growth and that the stimulation was due, at least in part, to the production of secretory factor(s). In subsequent experiments, follicles were cultured in media that had been preconditioned by previously cultured follicles. The concentration of FSH in the cultures determined the effect of the conditioned media: conditioned media was stimulatory to follicle growth when levels of FSH remained high throughout the culture, but inhibitory when FSH levels were dropped midway through the cultures. Heat inactivation removed this inhibitory effect, showing that the factor was likely to be a protein; addition of follistatin to the conditioned media did not alter its effect, indicating that the factor was unlikely to be activin. We have shown through a series of culture experiments that mouse follicles secrete factor(s) that can affect the development of other like-sized follicles when cultured from the late preantral to Graafian stages. Furthermore, we have shown that the effect (or production) of such factors is dependent on the FSH environment of the follicles.
- Open Access
- 1 August 2000
- Published by SAGE Publications in Anaesthesia and Intensive Care
- Vol. 28 (4) , 427-430
Clinical Evaluation of the Non-Invasive Cardiac Output (NICO) Monitor in the Intensive Care Unit
The Non-invasive Cardiac Output (NICO) monitor (Novametrix Medical Systems Inc., Wallingford, CT, U.S.A.) utilizes a minimally-invasive partial rebreathing method to determine cardiac output by means of a differential form of the Fick equation. We evaluated the NICO monitor by comparing its output to paired measurements obtained by the standard thermodilution (TD) technique in patients who had recently undergone cardiac surgery. Forty-two paired measurements were carried out in 12 patients. The correlation between the two methods was moderate with a correlation coefficient of 0.691. Repeated measures ANOVA showed that TD measures of cardiac output were significantly higher than those obtained by the NICO monitor (P=0.0003). Comparison of the two techniques using the method described by Bland and Altman showed decreased correlation at higher values of cardiac output. We conclude that the NICO monitor may well have a place in intensive care monitoring, provided patients are not breathing spontaneously and are able to tolerate a 4 mmHg rise in P a co 2 . It is less suitable for use in patients with a high cardiac output state.
- 1 August 2000
- Published by SAGE Publications in Anaesthesia and Intensive Care
- Vol. 28 (4) , 427-430
Open AccessClinical Evaluation of the Non-Invasive Cardiac Output (NICO) Monitor in the Intensive Care Unit
The Non-invasive Cardiac Output (NICO) monitor (Novametrix Medical Systems Inc., Wallingford, CT, U.S.A.) utilizes a minimally-invasive partial rebreathing method to determine cardiac output by means of a differential form of the Fick equation. We evaluated the NICO monitor by comparing its output to paired measurements obtained by the standard thermodilution (TD) technique in patients who had recently undergone cardiac surgery. Forty-two paired measurements were carried out in 12 patients. The correlation between the two methods was moderate with a correlation coefficient of 0.691. Repeated measures ANOVA showed that TD measures of cardiac output were significantly higher than those obtained by the NICO monitor (P=0.0003). Comparison of the two techniques using the method described by Bland and Altman showed decreased correlation at higher values of cardiac output. We conclude that the NICO monitor may well have a place in intensive care monitoring, provided patients are not breathing spontaneously and are able to tolerate a 4 mmHg rise in P a co 2 . It is less suitable for use in patients with a high cardiac output state.